Vanda Pharmaceuticals Inc. (VNDA) Rose To A 7-Month High After FDA Approval

Vanda Pharmaceuticals Inc. (VNDA) announced after the close Thursday that it has received FDA approval for Fanapt for maintenance treatment for schizophrenia in adults.

from RTT - Before the Bell http://ift.tt/1PfiZ6t
via IFTTT